Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials

BACKGROUND: In our previous works, we demonstrated that patients’ sex affects the efficacy of immune checkpoint inhibitors (ICIs) in patients with several advanced solid tumors. Here, we assessed the sex-based heterogeneity of efficacy of anti-programmed cell death protein 1 (anti-PD-1)/anti-program...

Descripción completa

Detalles Bibliográficos
Autores principales: Conforti, F., Pala, L., Pagan, E., Corti, C., Bagnardi, V., Queirolo, P., Catania, C., De Pas, T., Giaccone, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403740/
https://www.ncbi.nlm.nih.gov/pubmed/34455288
http://dx.doi.org/10.1016/j.esmoop.2021.100251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403740/
https://www.ncbi.nlm.nih.gov/pubmed/34455288
http://dx.doi.org/10.1016/j.esmoop.2021.100251

Ejemplares similares